Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Renvela in hyperphosphatemic CKD patients not on dialysis
NCT00833768Phase 3Terminated
- Sponsor
- Sanofi
- Start
- Jan 2009
- Primary completion
- Sep 2009
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 9
01
Overview
A Phase 3 trial of sevelamer carbonate in hyperphosphatemia, sponsored by Sanofi. Started Jan 2009; status: terminated.
02
Drugs
sevelamer carbonate
03
Conditions
hyperphosphatemia
Beyond the preview
Go deeper on NCT00833768.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00833768.